Eagle Bay Advisors LLC Sells 64 Shares of Chemed Co. (NYSE:CHE)

Eagle Bay Advisors LLC lessened its holdings in Chemed Co. (NYSE:CHE) by 35.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119 shares of the company’s stock after selling 64 shares during the quarter. Eagle Bay Advisors LLC’s holdings in Chemed were worth $63,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. American National Bank & Trust bought a new position in Chemed during the third quarter valued at about $61,000. GAMMA Investing LLC grew its position in shares of Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after acquiring an additional 52 shares during the period. Quarry LP increased its stake in shares of Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after purchasing an additional 166 shares during the last quarter. Sound Income Strategies LLC bought a new stake in shares of Chemed in the 3rd quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC lifted its stake in Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after purchasing an additional 324 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at approximately $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Brian C. Judkins bought 145 shares of the firm’s stock in a transaction on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. The trade was a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 3.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Chemed Price Performance

NYSE:CHE opened at $530.55 on Tuesday. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62. The stock’s fifty day moving average price is $545.33 and its two-hundred day moving average price is $562.73. The company has a market cap of $7.98 billion, a P/E ratio of 26.81, a P/E/G ratio of 2.32 and a beta of 0.47.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same quarter in the prior year, the business earned $5.32 EPS. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio is presently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.